← Evidence map

ReviewBiotech (Basel (Switzerland))2026

Regulatory Convergence in Cell and Gene Therapy: Harmonizing Quality, CMC, and Approval Pathways Across the FDA, EMA, PMDA, and Emerging Markets.

Nagendra Verma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Regulatory Convergence in Cell and Gene Therapy: Harmonizing Quality, CMC, and Approval Pathways Across the FDA, EMA, PMDA, and Emerging Markets. | OpenQuestion